Subject index volume XVI

SUBJECT (ab.)

= Abstract;

(CPC)

INDEX

= Clinico-pathologic

Abstracts of Association for the Study of Liver Diseases, fourth annual meeting, October 29, 1953, 902 of Southern Society for Clinical Research, seventh annual meeting, .Ianuary 30, 1954, 590 Achromycin (ab.), 612 .4CTH and the nephrotic syndrome (ab.), 600 in rheumatic fever, 168 Adenomatosis of endocrine glands, 363 Adrenal cortex extract and kidney cholinesterasr (ab.), S94 cortical deficiency, 328 hyperplasia, cortisone test in, 340 neoplasia, cortisone test in, 340 steroids and alkalosis (ab.), 608 Adrenalectomy and kidney cholinesterase (ab.), 594 Alcoholism and heat pyrexia (ab.), 609 Alkalosis, hypochloremic, and adrenal steroids (ab.), 608 Amino acid intake and metabolic response to cortisone (ab.), 592 metabolism, 504 Amyloidosis and bone marrow plasmacytosis in hyper-

Conference;

XVI (E.)

= Editorial

Bacterial

pyrogens, effect of, on splanchnic metabolism and cardiac output (ab.), 595 Banthinc and cardiac mechanism, 516 Blood groups and transfusion reactions, 878 volume in epidemic hemorrhagic fever, 654 Bone marrow plasmacytosis and sulfonamide hypersensitivity, 749 Bones of feet, idiopathic atrophy of, 909 Botulinum toxin poisoning (ab.), 600 Bronchiolectasis (CPC), 449 Bronchogenic carcinoma, 404 Brucellosis melitensis, cortisone and antibiotics in, 8 IO Butazolidin in gout, 212 in rheumatoid arthritis, 18

I

C arbon

dioxide narcosis and artificial respiration, 4 Carcinoma and polyps of colon and rectum, 555 bronchogenic, in young men, 404 metastatic, of undetermined primary site (
sensitivity to sulfonamides, 749 Androgens and estrogens, effect of, on lipid and lipoprotein metabolism (ab.), 594 Anemia, hemolytic, viremia in (ab.), 612 Anesthesia and loss of K from myocardial tissue (ab.), 596 Aneurysm embolic mycotic, 246 of the aortic sinus (CPC), 894 .‘+nticoagulant, circulating, and hemorrhagic diathesis, 756 Aortic insufficiency and right-sided failure (CP(:), 894 sinus (CPC), 894 Apex beat, mechanism of (ab.), 596 .%presoline, pharmacology of (ab.), 606 Arterial occlusion and right heart compensation (ah.), 598 .Irtihcial respiration and carbon dioxide narcosis, 4 Ascites, mechanism of, 434 Aspirin, ACTH and cortisone in rheumatic fever, 16X .Association for the Study of Liver Diseases, fourth annual meeting, October 29, 1953, 902 i\theroscherosis, serum lipoproteins in, 818 Atrophy of bones of feet, 909

Bacterial endocarditis, 535 and aneurysms, 246 streptomycin and erythromycin

VOLUME

in (ab.), 613 918

Subject Colchicine,

intravenous,

in acute gout, 218

Colloidal AUr9”, studies with (ab.), 600 Colon, polyps of, 555 Combined staff clinic (Columbia Univ.) blood groups and transfusion reactions, 878 Compounds A and F and changes in body composition (ab.), 598 Conferences on therapy (Cornell Univ.) most effective application of therapeutic measures in the management of congestive failure, 118 drugs in the diagnosis of one of the curable forms of hypertension, 574 Congestive failure, therapy in, 118 Coronary QR wave, origin of, 490 Corticoids, excretion of, and emotional tension (ab.), 608 Cortisone and antibiotics in acute brucellosis melitensis, 810 in rheumatic fever, 168 in rheumatoid arthritis, 181 response to, and amino acid intake (ab.), 592 test in adrenal hyperplasia and neoplasia, 340 therapy and gout, 292 CR5’ in whole blood (ab.), 602 Creatinine, excretion of, and emotional tension (ah.), 608 Cryptorchidism, histopathology of, 346

D eath

cause of (E.), 769 in epidemic hemorrhagic fever, 629 ljrpolarization complex in subendocardial infarction, 469 Ihabetes and sodium Huoracetate (ab.), 592 insipidus, renal responses to water and antidiuretic hormone in, 220 Diamox diuresis (ab.), 607 Dietotherapy of infectious hepatitis (ab.), 902 Diuresis, diamox for (ab.), 607 Diuretics, oral, bioassay of (ab.), 610 Drugs in diagnosis of hypertension, 574 Dystrophia myotonica with sprue-like symptoms, 614

Index Epidemic

fever, cardiac output in, 668

Fanconi syndrome and renal function, 138 Fat metabolism, 504 Fever of unknown origin (CPC), 581 Foreword to symposium on epidemic hemorrhagic 619

fever,

G out

acute, colchicine in, 2 18 and cortisone therapy, 292 phenylbutazone in, 212 Granulocytes, mature, in leukemic blood (ab.), 601 Growth hormone content of human plasma (ab.), 608

H eart

Edema and malnutrition (ab.), 610 Electrocardiogram and hiccup, 73 and subendocardial region, 469 in potassium depletion, 395 Electrocardiographic changes after increased sodium chloride cab.), 599 Flertrolyte abnormalities in epidemic hemorrhagic fever, 677 Electrophoresis and serum lipoproteins, 818 in multiple myeloma, 822 Emphysema, pulmomary, ventilation in, 55, 80 Endocrine glands, adenomatosis of, 363 Epidemic hemorrhagic fever blood volume in, 654

hemorrhagic

clinical course of, 619 electrolyte abnormalities in, 677 hematocrit and serum proteins in, 662 hemostatic defect in, 651 L-arterenol in, 683 pathology of fatal cases in, 639 physiologic derangements in, 690 plethysmography in, 664 renal function in, 671 sequelae of, 629 symposium on, 6 17 -709 Epinephrine and insulin hypoglycemia (ab.), 604 in human urine, 310 Krythrocytes life span of (ab.), 597 tagged with radioactive chromium, survival of (ab.), 611 Esophageal varices and physical findings (ab.), 904 hemorrhage from, 459 Estrogen therapy and urinary gonadotropin levels (ab.), 596 Ethics and placebo therapy, 854 Exercise, physical, and cerebral circulation, 549

disease and pulmonary hypertension, 12 cyanotic, tuberculosis and, 528 human, metabolism of, 504 Hematocrit in epidemic hemorrhagic fever, 662 Hematopoiesis, extramedullary, and myelotibrosis (CPC), 127 Hemochromatosis and transfusional hemosiderosis, 382 Hemoglobin C, homozygous (ab.), 611 Hemophilia and plasma thromboplastin component, 153 Hemorrhage from eosphageal varices, 459 Hemorrhagic diathesis and circulating anticoagulant, 756 Hemosiderosis, transfusional, and hemochromatosis, 382 Hemostatic defect in epidemic hemorrhagic fever, 651 Hepatic insufficiency (CPC), 272 veins, thrombi of (CPC), 272

Subject Hepatitis acute, nitrogen balance in (ab.), 907 cholangiolitic, phosphatase-cholesterol index in (at,.), 906 infectious, dietotherapy in (ab.), 902 recovery from, and physical activity, 780 viral, etiology and epidemiology of (ab.), 902 histopathology of (ab.), 904 Hepatobiliary disease, serum mucoprotein in (ab.), 905 Hexamethonium chloride in malignant hypertension (ab.), 607 Hiccup and electrocardiogram, 73 Hodgkin’s disease abdominal type (CPC), 581 strum proteins in, 833 1-Hydrazinophthalazine in malignant hypertension (ah.), 607 pharmacology of (ab.), 606 Hydrocortisone, effect of on leukocytes, during ACI’H therapy (ab.), 597 Hypertension acute, and stimulation of cerebral cortex (ab.), 60s and pentapyrrolidinium (ab.), 593 and Rauwolfia serpentina (ab.), 605 curable, drugs in diagnosis of, 574 diagnosis of, 574 malignant, hexamethonium and l-hydrazinophtalazinc in (ab.), 607 sympatho-adrenal surgery in (ab.), 607 portal, shunt operations for, and ether time test (ab.), 907 surgery for, 874 pulmonary, 4 and heart disease, 12 Hypotension, cerebral hemodynamics in (ab.), 592 Hypothromboplastinemia and hemorrhagic diathesis, 756

I,cukemia, mature granulocytes srrum proteins in. 842 I .i\w

idiopathic, and unidentified cells (ab.), 906

pigment

in (ab.), 601

cdl damage, tctrazolium reduction test for (ab.), 908 unidentified pigment in (ab.), 906 cirrhosis of, 863 disease, morphologic function tests, 565

considerations

in, 98

of man, dog and rat, comparison of (ab.), 906 physiology of, 256 polyvinyl pyrrolidone deposits in (ab.), 905 Lung capacity in disease, 39 compliance and pulmonary vascular chaqqc~ 606 Lymphoma, malignant, serum proteins in, 833

(at,.),

M alformations and stenosis in portal venous system, 450 Malnutrition and edema (ab.), 610 Mechanism of ventricular activity, 469, 490 Metabolism and physical exercise, 549 basal, and body fat content (ab.), 604 electrolyte, during hypercapnia (ab.), 595 lipid, and increased sodium chloride (ab.), 599 and lipoprotein, gonadal steroids and (ab.), 594 of human heart, 504 splanchnic, and bacterial pyrogens (ab.), 595 tissue, in tuberculosis (ab.), 602 Molecules, measurements and men (ab.), 590 Morphology in liver disease, 98 Mural thrombi, auricular, formation of, 543 Muscles, respiratory, tic of, 61 Myelofibrosis and hematopoiesis (CPC), 127 Myeloid metaplasia of spleen and retroperitoneal tissrtcs (CPC), 127 Myeloma, multiple, electrophoresis in, 822 Myxedema, renal clearance of insulin in (ab.), 613

I-131 and changes in thyroid tissue, 372 I-131 in whole blood (ab.), 602 Ileostomy and small intestinal function, 237 Infections, upper respiratory, oral penicillin G in, 804 Insulin hypoglycemia and epinephrine and nor-epinephrine (ab.), 604 Intestine, sulfonamide conversion in (ab.), 593 Intracardiac shunts and pulmonary stenosis, 521 Intravascular resistance (I%), 465

.J,dundlce,

index

N arcosis, carbon dioxide, and artilicial respiration, Nature of the engine (E.), 307 Needle biopsies, renal, findings in (ab.), 609 Nephrotic syndrome and ACTH (ab.), 600 Nickerson-Kveim reaction in sarcoidosis, 790 Nitrogen balance in acut? hepatitis (ab.), 907 Nocardiosis, 295 Nor-epinephrine and insulin hypoglycemia (ab.), 604 and sodium and potassium exchanges (ah.), 605 in human urine, 310

in liver

K etone metabolism, 504 Kidney cholinesterase activity and steroids (ab.), 594 Kinetocardiogram, use of, in mitral stenosis (ab.), 603

Obesity,

studies in (ab.), 603

Penicillin G, oral, in upper respiratory infections, Pentapyrrolidinium hypertension (ab.), 593 Phenylbutazonp in gout, 212 in rheumatoid arthritis, 181

L- arterenol

in epidemic hemorrhagic fever, 683 Lesions of malignant rheumatoid arthritis, 197 1,eukemia lymphatic, and venous “spiders,” 304 920

4

804

Subject Phenochromocytoma, Phosphatasr-cholesterol

diagnosis of, 310 index in cholangiolitic

Renal, hepatitis

alcoholism

tubular phenomena and a carbonic inhihitor (ab.), 612

anhydrasc

Respiratory infection, oral penicillin t; in, X04 muscles, tic of, 61 Rheumatic fever, ACTH and cortisone in, 168 Rheumatoid arthritis, lesions of, 197 phenylbutazone in, 181 sheep cell agglutination reaction in, 191 spondylitis with carditis, 284 Right heart compensation during arterial occlusion (ab.), 598 Roentgenograms, chest, and lung capacity, 39

(ab.), 906 Physical activity and recovery from hepatitis, 780 Physiologic derangements in epidemic hemorrhagic fever, 690 Physiology of liver, 256 Piromen, effect of on leukocytes, during cortisone therapy (ah.), 597 Placebo therapy and ethics, 854 response, 770 Plasma and ascitic fluid albumin exchange (ab.), 611 human, growth hormone content of (ab.), 608 thromboplastin component deficiency, 153 Plethysmography in epidemic hemorrhagic fever, 664 Pneumoplethysmography in vascular phenomena (ah.), 601 Poisoning vitamin ,4, in adults, 729 with botulinurn toxin (ab.), 600 Polyps of colon and rectum, 555 Polyvinyl pyrrolidone deposits in liver (ah.), 905 Portal hypertension, surgery for, 874 Post-prandial decline in T wave (ab.), 607 Potassium and rubidium in organs of dog (ah.), 598 delicit and serum concentration, 395 depletion, electrocardiogram in, 395 loss and anesthetic agents (ab.), 596 Prothrombin and related factors (ab.), 598 Psychosomatic hypotheses in ulcerative colitis, 416 medicine (E.), 163 Pulmonary rmphysema and head-down position, 55 hypertension, 4 in heart disease, 12 stenosis and intracardiac shunts, 521 vascular changes and lung compliance (ah.), 606 venous drainage, 23 ventilation in emphysema, 80 Pyrexia,

Index

Salt (E.), 1 Sarcoidosis and geography (ab.), 604 Nickerson-Kveim reaction in, 790 Sclerosis, tuberous, with pulmonary manifestations, 764 Screening methods for diagnosis of pheorhromorytoma, 310 Seminars on liver disease cirrhosis of liver, 863 liver disease-morphologic considerations, 98 meaning of liver function tests, 565 mechanism of ascites; a physiologic appraisal, 434 physiology of the liver, 256 present status of surgery for portal hypertension, 874 viral hepatitis; problems and progress to 1954, 710 Serum albumin tagged with I-131 in ascites (ab.), 611 cholesterol methods (ab.), 601 lipoproteins in atherosclerosis and paper c-lectrophoresis, 818 mucoprotein in hepatobiliary disease (ah.), 905 proteins in Hodgkin’s disease and lymphoma, 833 in leukemia, 842 total, in epidemic hemorrhagic fever, 662 Sheep cell agglutination reaction in rheumatoid arthritis, 191 Shunt operations for portal hypertension, ether time test in (ab.), 907 Small bowel function with ileostomy, 237 Sodium fluoroacetate, diabetogenic effect of (al,.), 592 Southern Society for Clinical Research, seventh annual meeting, January 30, 1954, 590 Spleen and retroperitoneal tissues, myeloid mrtaplasia of (CPC), 127 Spondylitis, rheumatoid, and carditis, 284 Sprue-like symptoms and dystrophia myotonica, 614 Streptomycin and erythromycin in bacterial endocarditis (ab), 613 Subendocardial infarction, depolarization complex in, 469 region and normal electrocardiogram, 469 Sulfonamide conversion in intestine (ab.), 593 hypersensitivity and amyloidosis and hone marrow plasmacytosis, 749

and heat (ah.), 609

Rauwolha serpentina in hypertension (ah.), 605 Rectum, polyps of, 555 Rectum-to-lung ether test in shunt operations (ab.), 907 Red cell survival and N’“-labeled erythrocytes (ah.), 597 Renal clearance of inulin in myxedema (ab.), 613 disease, chronic, responses to water and antidiuretic hormone in, 220 failure following calcium and alkali in peptic ulcer, 23 I function in epidemic hemorrhagic fever, 671 in subject with Fanconi syndrome, 138 needle biopsies, findings in (ab.), 609 responses to water and antidiuretic hormone in diabetes, 220 921

Subject Surgery for portal hypertension, 874 Sympatho-adrenal surgery in malignant hypertension (ab.), 607 Symposium on epidemic hemorrhagic fever analysis of sequential physiologic derangements in epidemic hemorrhagic fever, 690 blood volume in epidemic hemorrhagic fever, 654 cardiac output in epidemic hemorrhagic fever, 668 clinical course of epidemic hemorrhagic fever, 619 electrolyte abnormalities in epidemic hemorrhagic fever, 677 foreword, 617 hematocrit and total serum proteins in epidemic hemorrhagic fever, 662 hemostatic defect in epidemic hemorrhagic fever, 651 L-arterenol in the treatment of hemorrhagic fever, 683 pathology of thirty-nine fatal cases, 639 plethysmographic studies in epidemic hemorrhagic fever, 665 renal function in epidemic hemorrhagic fever, 671 sequelae of epidemic hemorrhagic fever, 629

Testes, retained and scrotal, histology of, 346 Tetrazolium reduction test for liver cell damage 908 Thrombi of hepatic veins (CPC), 272

Index Thrombosis, intravascular, and trypsin (ab.), 595 Thyroid tissue, changes in, after I-131, 372 Tic of respiratory muscles, 61 Transfusion reactions and blood groups, 878 Triglyceride, synthetic, use of (ab.), 599 Trypsin in intravascular thrombosis (ab.), 595 Tuberculosis and cyanotic heart disease, 528 tissue metabolism in (ab.), 602

Ulcer, therapy, renal failure following, 231 Ulcerative colitis, 416 CJrinary gonadotropin levels in castrate woman (ab.), 596

V enous

drainage, pulmonary, 23 “spiders” in lymphatic leukemia, 304 Ventilation, pulmonary, in emphysema, 55, 80 Ventricular activity, mechanism of, 469, 490 contraction and relaxation in mitral stenosis (ab.), 603 Viral hepatitis, 710 etiology and epidemiology of (ab.), 902 histopathology of (ab.), 904 Viremia in hemolytic anemia (ab.), 612 Vitamin A poisoning in adults, 729

(ab.),

922